NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE252938 Query DataSets for GSE252938
Status Public on Mar 01, 2024
Title BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor
Organism Homo sapiens
Experiment type Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
Summary This SuperSeries is composed of the SubSeries listed below.
 
Overall design Refer to individual Series
 
Citation(s) 40089460
Submission date Jan 10, 2024
Last update date Mar 19, 2025
Contact name Xiaoping Su
E-mail(s) xsu1@mdanderson.org
Phone 8328179083
Organization name MD Anderson Cancer Center
Street address 7300 Brompton St, Apt 5633
City Houston
State/province Texas
ZIP/Postal code 77025
Country USA
 
Platforms (1)
GPL24676 Illumina NovaSeq 6000 (Homo sapiens)
Samples (34)
GSM8010532 MOLM13 Control 1
GSM8010533 MOLM13 Control 2
GSM8010534 MOLM13 100 nM FHD-286 1
This SuperSeries is composed of the following SubSeries:
GSE252933 BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor (Bulk ATAC-Seq)
GSE252934 BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor (Bulk RNA-Seq)
GSE252935 BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor (ChIP-Seq)
Relations
BioProject PRJNA1063269

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE252938_RAW.tar 11.0 Gb (http)(custom) TAR (of BROADPEAK, CSV, H5, MTX, NARROWPEAK, TBI, TSV)
SRA Run SelectorHelp

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap